Example: Heart Attack

Search clinical trials for: Dose decrease

Total 7779 results

NCT06149442

Active, not recruiting

The Importance of the Number of Incisions in the Effectiveness of Dry Needling

Neck Pain
NCT04724980

Active, not recruiting

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Papillomavirus Infections | Recurrent Respiratory Papillomatosis | Papillomaviridae
NCT03424824

Completed

Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment

Alcohol Use Disorder
NCT04678063

Completed

Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma

Allergy | Allergic Asthma | Allergy to Cats
NCT01509846

Completed

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Shigellosis
NCT05907213

Completed

Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1)

Pain, Postoperative | Depression, Postpartum
NCT03902054

Completed

Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine.

Polio and Post-Polio Syndrome
NCT07122986

Recruiting

A Study to Learn About a Vaccine Against E Coli in Healthy Adults

Healthy Participants
NCT07598279

Not yet recruiting

Peripheral Vascular Disease as a Clinical Trigger for Opportunistic Lung Cancer Screening Referral: An Implementation Study (PVD-Lungs)

Peripheral Vascular Diseases | Lung Cancer | Ankle Brachial Index | Low Dose Computed Tomography
NCT07301229

Not yet recruiting

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07269782

Recruiting

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC

Non Small Cell Lung Cancer
NCT06904729

Recruiting

Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children (CAR-T)

Lupus Nephritis
NCT06264622

Recruiting

ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension (GARDOSE)

Hypertension
NCT05113849

Recruiting

Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)

COVID-19
NCT04794101

Active, not recruiting

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

X-Linked Retinitis Pigmentosa
NCT03972930

Active, not recruiting

Hypofractionated Radiotherapy for Soft Tissue Sarcomas

Soft Tissue Sarcoma
NCT07221175

Withdrawn

Operator Radiation Dose Using Ultra-Low Fluoroscopic Pulse Rate Versus Standard In Performing Coronary Angiography Via Right Radial Artery

Radiation Exposure | Radiation Exposure to Operator
NCT04159415

Completed

Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy

Generalized Lipodystrophy
NCT05740813

Completed

HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Amyotrophic Lateral Sclerosis
NCT02631044

Completed

Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)

Follicular Lymphoma | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell Lymphoma | Mantle-cell Lymphoma
NCT02278822

Completed

Oral Liposomal Glutathione Supplementation in Healthy Subjects

Healthy
NCT01970137

Completed

A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration
NCT01970124

Completed

A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration
NCT01348074

Completed

Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist (DOSIDO)

Atrial Fibrillation | Surgery | Venous Thromboembolism | Heart Valve Disease
NCT01926002

Withdrawn

A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)

Asthma
NCT02140346

Completed

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPD

Chronic Obstructive Pulmonary Disease
NCT01081821

Completed

Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent

Healthy
NCT01685151

Withdrawn

A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder

Bipolar Disorder
NCT06683521

Recruiting

Immunologic Basis of Food Protein-Induced Enterocolitis Syndrome (INFINITY)

Food Protein-Induced Enterocolitis Syndrome
NCT04801888

Completed

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

COVID-19 | Influenza
NCT02255279

Completed

Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.

Influenza
NCT06006689

Recruiting

Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)

Diabetic Kidney Disease
NCT05863364

Recruiting

Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis (RPPCLC)

Decompensated Cirrhosis
NCT05181709

Completed

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

SARS-CoV-2
NCT02687542

Terminated

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Parkinson Disease
NCT07507058

Not yet recruiting

Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma
NCT07487805

Not yet recruiting

Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC) (ICONIC)

Solid Tumor, Adult
NCT07247682

Not yet recruiting

Dose-escalation of Rectal Indomethacin for Preventing PEP

Post-ERCP Pancreatitis
NCT07096934

Not yet recruiting

Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care

Diabetic Foot Ulcer (DFU)
NCT06756451

Recruiting

This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.

Hematologic Malignancies
NCT05543343

Recruiting

Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Pulmonary Disease, Chronic Obstructive
NCT05314777

Recruiting

Efficacy of Extracorporeal Shock Wave Therapy in Carpal Tunnel Syndrome

Carpal Tunnel Syndrome
NCT04054167

Active, not recruiting

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma
NCT04415593

Completed

High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety

Peanut Allergy
NCT05025462

Completed

Salmon Peptide Fraction: Safety and Cardiometabolic Health (SPF1)

Metabolic Syndrome
NCT05387083

Completed

A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05

Healthy Volunteer
NCT05918757

Active, not recruiting

Efficacy and Safety of Administration of High Levels of Protein to Critically Ill Patients. (FISIO)

Intensive Care Unit Acquired Weakness
NCT01970111

Completed

An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration
NCT01690390

Unknown

Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease

NSCLC
NCT01787214

Terminated

Walnuts and Glucose Variability

Type-2 Diabetes

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations